Kenya sits on the equator between 4°N and 4°S latitude, straddling multiple disease zones that require specific medical preparation. The country ranges from sea level on the Indian Ocean coast to 5,199 meters at Mount Kenya's summit, creating distinct health risks at different elevations. Nairobi sits at 1,795 meters where altitude affects some travelers. Mombasa at sea level carries different disease vectors than the highlands. The Great Rift Valley contains lakes with pH levels that affect waterborne disease transmission. Northern regions including Lake Turkana and the Chalbi Desert present dehydration risks absent in the Lake Victoria basin. Medical infrastructure concentrates in Nairobi with secondary capacity in Mombasa and Kisumu, while rural areas including much of Tsavo National Park, Samburu National Reserve, and northeastern territories near Garissa have limited immediate advanced care.
Yellow fever vaccination certificate is required for entry if arriving from a country with yellow fever transmission risk, as defined by Kenya's Ministry of Health current country list. The vaccine becomes valid 10 days after administration and remains recognized for life under World Health Organization 2016 amendments, though individual countries may maintain different policies. Kenya itself contains no endemic yellow fever zones but enforces this requirement strictly at Jomo Kenyatta International Airport in Nairobi and Moi International Airport in Mombasa. Travelers transiting through Addis Ababa, Kigali, or other African airports typically trigger this requirement regardless of whether they left the airport. Airlines deny boarding without the yellow certificate if routing indicates requirement. Vaccination is available at designated centers globally, requiring advance appointment in most locations. The vaccine is contraindicated for infants under 9 months, pregnant women, severely immunocompromised individuals, and those with thymus disorders or severe egg allergy. Medical waiver letters are recognized but may result in entry delays for health screening.
Malaria transmission occurs throughout Kenya below 2,500 meters elevation with varying intensity. The entire Indian Ocean coast including Mombasa, Malindi, Diani Beach, and Lamu experiences year-round transmission. Lake Victoria basin areas including Kisumu show high transmission rates. Maasai Mara National Reserve, Amboseli National Park, Tsavo East and West National Parks, Samburu National Reserve, and Meru National Park all fall within malaria zones. Nairobi city proper sits above the transmission threshold though Nairobi National Park's lower-lying southern sections carry minimal risk. Mount Kenya National Park and the Aberdare Range above 2,500 meters are malaria-free. Plasmodium falciparum accounts for approximately 98% of cases, with this species responsible for severe malaria complications. Anopheles gambiae and Anopheles funestus mosquitoes transmit the parasite primarily between dusk and dawn. Chloroquine resistance is widespread across Kenya. Prophylaxis options include atovaquone-proguanil, doxycycline, and mefloquine, with selection depending on individual health factors, trip duration, and contraindications. Atovaquone-proguanil begins 1-2 days before arrival and continues 7 days after departure. Doxycycline begins 1-2 days prior and continues 28 days after. Mefloquine begins 2 weeks before and continues 28 days after. No prophylaxis provides 100% protection. Symptoms appear 7 days to several months after exposure. Any fever developing during or after travel to malaria areas constitutes a medical emergency requiring immediate blood testing.
Typhoid fever occurs throughout Kenya with higher incidence in areas with inadequate water treatment. The injectable Vi polysaccharide vaccine or oral Ty21a vaccine provides partial protection. The injectable version requires one dose 2 weeks before travel with protection lasting 2 years. The oral version requires 4 capsules on alternate days with protection lasting 5 years. Neither vaccine prevents all cases. Typhoid transmission links to contaminated food and water, particularly ice, raw vegetables washed in untreated water, and food from street vendors in Nairobi, Mombasa, Nakuru, and other urban centers. Outbreaks occur periodically in informal settlements. Symptoms include sustained fever, headache, and abdominal discomfort, appearing 6-30 days after exposure.
Hepatitis A virus transmits through contaminated food and water throughout Kenya. The vaccine provides long-term protection after a two-dose series, with the first dose effective 2 weeks after administration and the second dose 6-12 months later providing likely lifelong immunity. Single doses offer protection for at least one year. Hepatitis A incidence is higher in rural areas and informal urban settlements where water treatment is incomplete. Lake Naivasha's horticultural industry and Lake Victoria's fishing communities have documented cases. Markets in Nairobi, Kisumu, and Mombasa carry transmission risk through raw produce.
Hepatitis B transmits through blood, sexual contact, and contaminated medical equipment. The vaccine series involves three doses at 0, 1, and 6 months, though accelerated schedules exist. Healthcare exposure risk exists if requiring medical treatment in facilities with inconsistent sterilization practices. The virus prevalence in Kenya's general population ranges between 5-8% in various studies. Tattoos, piercings, dental work, and any procedure involving skin penetration carry risk if performed in non-sterile conditions.
Rabies exists throughout Kenya in dogs, bats, monkeys in forested areas including Kakamega Forest and Arabuko Sokoke Forest, and other mammals. Samburu National Reserve, Maasai Mara National Reserve, and Nairobi National Park all contain potential rabies vectors. Pre-exposure vaccination involves three doses over 21-28 days and does not eliminate the need for post-exposure treatment but reduces the number of required post-exposure doses from five to two and eliminates the need for rabies immunoglobulin, which is often unavailable outside Nairobi. Post-exposure treatment must begin immediately after any bite or scratch from a mammal. The virus is fatal once symptoms appear. Stray dogs populate Nairobi, Mombasa, and virtually all Kenyan towns. Monkeys at hotel grounds near parks may bite if fed. Bats inhabit caves including those at Hell's Gate National Park.
Cholera appears sporadically in Kenya, with outbreaks documented in informal settlements in Nairobi, refugee camps near Garissa, and Lake Victoria fishing communities. The oral cholera vaccine provides 65-85% protection for up to 2 years depending on formulation. Two doses 1-6 weeks apart are required. Cholera transmits through severely contaminated water and food, primarily affecting those consuming untreated water or raw seafood. Outbreaks intensify during flooding, including periodic Tana River floods. The disease causes rapid dehydration through profuse watery diarrhea.
Meningococcal meningitis occurs in Kenya with periodic outbreaks, particularly in the Rift Valley regions including Nakuru and Naivasha during dry seasons from December through March. The quadrivalent ACWY vaccine protects against four major strains. One dose provides protection for approximately 5 years. The disease transmits through respiratory droplets in crowded conditions. Symptoms include sudden high fever, severe headache, and neck stiffness, progressing rapidly.
Polio vaccination should be current for Kenya travel. The country documented vaccine-derived poliovirus cases in 2018-2020 though no wild poliovirus cases since 2013. A single adult booster of inactivated polio vaccine suffices if childhood series was complete. Some countries require proof of polio vaccination for travelers exiting Kenya to enter their borders.
Measles, mumps, and rubella immunity should be confirmed through vaccination or serology. Kenya experiences periodic measles outbreaks, with cases documented across all regions. Two MMR doses provide immunity in 97% of recipients. Adults born after 1957 without documented immunity should receive at least one dose.
Tetanus, diphtheria, and pertussis boosters should be current, with Tdap recommended every 10 years. Tetanus risk exists from soil contamination of wounds, common during activities in national parks and rural areas. Diphtheria cases occur sporadically in Kenya.
Tuberculosis prevalence in Kenya ranks among Africa's highest, with multidrug-resistant TB documented. The BCG vaccine is not routinely recommended for short-term travelers. Risk increases with prolonged close contact in crowded environments or healthcare settings. Symptoms include persistent cough lasting over 2 weeks, night sweats, and weight loss.